Skip navigation
|
Home
Contact us
Urdu
Confidential Helpline
0845 223 4424
[
Viewing options
]
Search
Hepatitis C Info
Treatment
Living with Hep C
Support
Get Involved
News & Resources
The Trust
News
Media centre
Resources
Trust Updates
Glossary
Community Links
News
2012
May
April
March
February
Town gets new hepatitis c co-ordinator
Researchers Show How Cholesterol Receptor Promotes HCV Cell Entry
Managing Side Effects of New Hepatitis C Protease Inhibitors
New hepatitis C pill Victrelis (Boceprevir) hampers HIV drugs
Hepatitis C breakthrough going to waste
Review of Liver Transplant Allocation Scheme
First UK guidelines on new drugs
Hull blood contamination victim wants hepatitis C inquiry
Canadian Researchers Make Progress in Quest for Hepatitis C Vaccine
Gilead Suffers First Hep C Drug Setback
Good 12-Week HCV Suppression with Oral Telaprevir/VX-222/Ribavirin Combo
Hepatitis C deaths up, baby boomers most at risk
Interferon-Based Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected Patients
Jon Secada Joins Hepatitis C Campaign
New Hep C drugs to be given to Lothian patients
The End of the Beginning and Possibly the Beginning of the End - Editorial
January
2011
2010
2009
2008
2007
2006
2005
2004
Home
>
News & Resources
>
News
>
2012
>
February
February
Hepatitis Info
About hep C
Just diagnosed?
Risk factors
Stages of hep C
Considering a test
Symptoms
Cirrhosis
Treatment
Considering
Choosing
Side effects
Preparing for treatment
New drugs
Interferon and ribavirin
Living with
Caring for yourself
Prevention
Mental and emotional
Alternative Medicine
Doctors and Consultants
Support
Support Groups
The importance of support
Helpline
Advocacy
Skipton fund
News & Resources
Resources
Newsletter
Media centre
Get Involved
Volunteering
Fundraising
Campaigning
Become a member
Get tested!
World hepatitis day
Personal stories
About us
Contact us
The team
The work we do
Donate
Resources
Media
About the Trust
[
Sign In
]
[
Sign Up
]